- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07723768
Neuromuscular and Structural Effects of Using Stretching During the Recovery Phase Between Sets of Upper and Lower-body Strength Training
Efectos Neuromusculares y Estructurales de la utilización de Estiramientos en la Fase de recuperación Entre Series de Entrenamiento de la Fuerza de Los Miembros Superiores e Inferiores
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
- Sonstiges: Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Sonstiges: Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Sonstiges: Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Madrid
-
Villaviciosa de Odón, Madrid, Spanien
- Edificio D
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
Male or female adults aged 18-30 years. Apparently healthy, with no medical conditions that contraindicate participation in resistance training.
A minimum of 6 consecutive months of resistance training experience. Regular resistance training participation of at least three sessions per week during the previous 6 months.
Previous experience performing the back squat and bench press exercises with correct technique.
Ability to perform maximal intended concentric velocity during resistance exercises.
Willingness to refrain from vigorous physical activity during the 24 hours preceding each testing and training session.
Ability and willingness to comply with all study procedures. Provision of written informed consent.
Exclusion Criteria:
Current musculoskeletal injury affecting the upper or lower limbs that limits participation in resistance training or testing.
Acute or chronic pain that is aggravated by the study exercises. Cardiovascular, neurological, metabolic, or other medical conditions that contraindicate vigorous physical exercise.
Current participation in another structured intervention study or clinical trial.
Inability to attend the scheduled assessments or training sessions. Failure to comply with the study protocol or training requirements. Withdrawal of informed consent at any stage of the study. Occurrence of an adverse event during the intervention that prevents continued participation.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Agonists stretching
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andere Namen:
|
|
Aktiver Komparator: Antagonists stretching
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andere Namen:
|
|
Placebo-Komparator: Control
Neuromuscular and structural effects of NOT using stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Acute resistance-training performance: total number of repetitions
Zeitfenster: First intervention session (Week 1), across the four training sets.
|
Total number of repetitions completed across four sets of bench press and back squat during the first intervention session.
Participants will perform each set to momentary muscular failure at maximal intended concentric velocity, using individualized absolute loads corresponding to 75% of the estimated one-repetition maximum (1RM) for the bench press and 80% of the estimated 1RM for the back squat.
Repetitions completed in each set and total repetitions per exercise will be recorded to compare the immediate effects of agonist stretching, antagonist stretching, and no stretching.
|
First intervention session (Week 1), across the four training sets.
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 2024-495
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .